LivaNova Chief Innovation Officer Ahmet Tezel disposes of shares worth $435,409.36
LIVN•Chief innovation officer reports share transaction
- Ahmet Tezel, chief innovation officer at LivaNova, reported a net decrease in ordinary share holdings to 6,090 on Aug. 11, 2026.
- Transaction included the exercise of 12,692 stock appreciation rights at USD 52.68.
- Disposition totaled 12,692 shares, including 2,675 shares sold at USD 77.74.
Related News
Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters Into Definitive Agreement To Acquire Moltex Energy’s Advanced Nuclear Technology Assets
MGRX•
Maze Therapeutics adds Paula Johnson, Sophie Kornowski to board
MAZE•
